The Effects of thiazides on eGFR changes in patients with advanced Chronic Kidney Disease

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/fe1cf8cb65cf691b35c5d23323bf29b3.pdf
The Effects of thiazides on eGFR changes in patients with advanced Chronic Kidney Disease

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Kosuke
Mochizuki
Kosuke Mochizuki kosuke7mochi@outlook.jp Kansai Electric Power Hospital Nephrology Osaka Japan *
Naohiro Toda natoda@kuhp.kyoto-u.ac.jp Kansai Electric Power Hospital Nephrology Osaka Japan -
Ryo Sato ryo.sato.a.m@gmail.com Kansai Electric Power Hospital Nephrology Osaka Japan -
Satoshi Kurahasi satoshi_k@kuhp.kyoto-u.ac.jp Graduate School of Medicine, Kyoto University Nephrology Kyoto Japan -
Takuya Takahashi takuya.t.0706@gmail.com Kansai Electric Power Hospital Center for Metabolism and Clinical Nutrition Osaka Japan -
Yuri Enomoto jiabenyouli664@gmail.com Kansai Electric Power Hospital Nephrology Osaka Japan -
Yoshinao Matsuyama yoshinao0812@gmail.com Kansai Electric Power Hospital Nephrology Osaka Japan -
Kansei Otsuka kyokui150018@gmail.com Kansai Electric Power Hospital Nephrology Osaka Japan -
Kyoka Fujita kyon.dt@gmail.com Kansai Electric Power Hospital Nephrology Osaka Japan -
Jun Takeoka juntakeoka@gmail.com Kansai Electric Power Hospital Nephrology Osaka Japan -
Hisako Hirashima pisa1018@yahoo.co.jp Kansai Electric Power Hospital Nephrology Osaka Japan -
Eri Muso emuso@kki.biglobe.ne.jp Kansai Electric Power Hospital Nephrology Osaka Japan -
Akira Ishii aish@kuhp.kyoto-u.ac.jp Kansai Electric Power Hospital Nephrology Osaka Japan -
-
-